A detailed history of Hsbc Holdings PLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 16,414 shares of MRVI stock, worth $72,549. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,414
Holding current value
$72,549
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $112,271 - $159,708
16,414 New
16,414 $136,000
Q2 2021

Aug 13, 2021

SELL
$32.46 - $45.0 $227,414 - $315,270
-7,006 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$25.8 - $38.49 $124,743 - $186,099
-4,835 Reduced 40.83%
7,006 $249,000
Q4 2020

Feb 12, 2021

BUY
$24.5 - $30.86 $290,104 - $365,413
11,841 New
11,841 $332,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $581M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.